Skip to content Skip to footer

BioMarin Pharmaceutical News

HomeAll PostsBioMarin Pharmaceutical News

Generative AI’s Role in Secure Software Development

AI and ML power better predictions for patient impact

Better Artificial Intelligence Stock: GSK or Eli Lilly?

How can AI be best harnessed for pharmacovigilance data?

GSK CEO Emma Walmsley says A.I. could improve Big Pharma’s most ‘profound’ challenge: R&D productivity

GSK CEO: AI could fix Big Pharma’s R&D inefficiency

PathAI taps AI pathology tool for GSK NASH trial

PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial

GSK Digital & Tech Executive Takes Drug-Hunting Inspiration from Outer Space